These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17018586)

  • 1. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast.
    Ding L; Kleer CG
    Cancer Res; 2006 Oct; 66(19):9352-5. PubMed ID: 17018586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues.
    Ding L; Erdmann C; Chinnaiyan AM; Merajver SD; Kleer CG
    Cancer Res; 2006 Apr; 66(8):4095-9. PubMed ID: 16618729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.
    Raaphorst FM; Meijer CJ; Fieret E; Blokzijl T; Mommers E; Buerger H; Packeisen J; Sewalt RA; Otte AP; van Diest PJ
    Neoplasia; 2003; 5(6):481-8. PubMed ID: 14965441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
    Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development.
    Kunju LP; Cookingham C; Toy KA; Chen W; Sabel MS; Kleer CG
    Mod Pathol; 2011 Jun; 24(6):786-93. PubMed ID: 21399615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.
    Zeidler M; Kleer CG
    J Mol Histol; 2006 Sep; 37(5-7):219-23. PubMed ID: 16855786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
    Kleer CG; Cao Q; Varambally S; Shen R; Ota I; Tomlins SA; Ghosh D; Sewalt RG; Otte AP; Hayes DF; Sabel MS; Livant D; Weiss SJ; Rubin MA; Chinnaiyan AM
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11606-11. PubMed ID: 14500907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.
    Li X; Gonzalez ME; Toy K; Filzen T; Merajver SD; Kleer CG
    Am J Pathol; 2009 Sep; 175(3):1246-54. PubMed ID: 19661437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
    Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].
    Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):253-8. PubMed ID: 17706117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line.
    Karanikolas BD; Figueiredo ML; Wu L
    Mol Cancer Res; 2009 Sep; 7(9):1456-65. PubMed ID: 19723877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
    Lin L; Pathmanathan N
    Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent advances on EZH2 in malignant tumors].
    Li J; Fan QH
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):856-8. PubMed ID: 20193471
    [No Abstract]   [Full Text] [Related]  

  • 17. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.
    Weinstat-Saslow D; Merino MJ; Manrow RE; Lawrence JA; Bluth RF; Wittenbel KD; Simpson JF; Page DL; Steeg PS
    Nat Med; 1995 Dec; 1(12):1257-60. PubMed ID: 7489405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.
    Hussein YR; Sood AK; Bandyopadhyay S; Albashiti B; Semaan A; Nahleh Z; Roh J; Han HD; Lopez-Berestein G; Ali-Fehmi R
    Hum Pathol; 2012 Oct; 43(10):1638-44. PubMed ID: 22436627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
    Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS
    Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
    Gong Y; Huo L; Liu P; Sneige N; Sun X; Ueno NT; Lucci A; Buchholz TA; Valero V; Cristofanilli M
    Cancer; 2011 Dec; 117(24):5476-84. PubMed ID: 21713757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.